Tvaster Genkalp
Company Details
Status: Private
Employees: 1-10
Location:
TICEL BIOPARK, Chennai, IN
Type:
sample
sample
Technology:
sample
About: Tvaster Genkalp is a Molecular Diagnostics company, established in May 2021, specialising in Liquid Biopsy, offering blood based cancer diagnostic solutions. With innovative approach and commitment to quality, Tvaster has developed a groundbreaking screening test for Hepatocellular carcinoma (HCC) called Episcreen™ Liver.
Episcreen™ Liver represents a major leap forward in the early detection of liver cancer (HCC). Rigorously validated through a study involving over 750 patients, this technology has demonstrated exceptional accuracy, far surpassing the current standard blood-based biomarker, AFP. The recent clinical study revealed that Episcreen™ Liver achieved an impressive sensitivity of 90%, in stark contrast to AFP's 50%. Moreover, Episcreen™ Liver identified 92% of HCC cases missed by AFP, offering a potentially life-saving solution for countless individuals.
Tvaster is dedicated to enhancing early cancer detection and improving patient outcomes through its state-of-the-art diagnostic solutions.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Tvaster Genkalp | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.